ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment

Title
ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment
Authors
Keywords
-
Journal
MOLECULAR CANCER THERAPEUTICS
Volume 17, Issue 6, Pages 1156-1166
Publisher
American Association for Cancer Research (AACR)
Online
2018-03-15
DOI
10.1158/1535-7163.mct-16-0847

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now